This is precisely where the combination with microneedling becomes clinically meaningful, and why we approach GHK-Cu both as an injectable and as a post-needling topical
B12 injections are contraindicated for individuals with Lebers hereditary optic neuropathy, severe kidney disease, known cobalt or cobalamin allergy, and polycythemia vera
Current Pharmaceutical Design, 21(9), 11211125
There arent that many other substances people are injecting into themselves where you see that the clinical evidence is so lacking. In recent years, the FDA has warned Americans about the risks of injecting peptides like BPC-157 and TB-500
BPC 157, also known as PLD-116, PL-10, PL14736 [9], or Bepectin [10,11,12,13,14,15,16,17], has recently attracted considerable attention as a potential drug candidate that is stable in acidic environments and has no serious adverse effects [18], although it has been known to cause pain and/or necrosis when injected in an aqueous solution or in physiological saline [19]
View the complete DSIP (Delta Sleep-Inducing Peptide) research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ
